These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34540215)

  • 21. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration.
    Malamos P; Sacu S; Georgopoulos M; Kiss C; Pruente C; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4926-33. PubMed ID: 19494200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of retinal vessel density in non-exudative macular neovascularization: a retrospective study.
    Gao Y; Zhang S; Zhao Y; Yang T; Moreira P; Sun G
    Front Med (Lausanne); 2023; 10():1219423. PubMed ID: 38239611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Coherence Tomography Characteristics of Quiescent Type 1 Neovascularization in Eyes with Nonexudative Age-related Macular Degeneration.
    Menteş J; Yıldırım Ş
    Turk J Ophthalmol; 2019 Apr; 49(2):84-88. PubMed ID: 31055893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration.
    Arrigo A; Amato A; Barresi C; Aragona E; Saladino A; Pina A; Calcagno F; Bandello F; Battaglia Parodi M
    Ophthalmol Ther; 2022 Feb; 11(1):377-386. PubMed ID: 34923601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choroidal Neovascularization Analyzed on Ultrahigh-Speed Swept-Source Optical Coherence Tomography Angiography Compared to Spectral-Domain Optical Coherence Tomography Angiography.
    Novais EA; Adhi M; Moult EM; Louzada RN; Cole ED; Husvogt L; Lee B; Dang S; Regatieri CV; Witkin AJ; Baumal CR; Hornegger J; Jayaraman V; Fujimoto JG; Duker JS; Waheed NK
    Am J Ophthalmol; 2016 Apr; 164():80-8. PubMed ID: 26851725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative quantitative analysis of optical coherence tomography angiography in varied morphologies of macular neovascularization following intravitreal conbercept and ranibizumab treatments for neovascular age‑related macular degeneration.
    Li J; Yang Z; Li X; Li D; Yang J; Dang M
    Exp Ther Med; 2024 May; 27(5):214. PubMed ID: 38590577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotational Three-dimensional OCTA: a Notable New Imaging Tool to Characterize Type 3 Macular Neovascularization.
    Borrelli E; Sacconi R; Klose G; de Sisternes L; Bandello F; Querques G
    Sci Rep; 2019 Nov; 9(1):17053. PubMed ID: 31745216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Color Fundus Autofluorescence to Determine Activity of Macular Neovascularization in Age-Related Macular Degeneration.
    Vujosevic S; Toma C; Sarao V; Veritti D; Brambilla M; Muraca A; De Cillà S; Villani E; Nucci P; Lanzetta P
    Transl Vis Sci Technol; 2021 Feb; 10(2):33. PubMed ID: 34003918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Projection artifact removal improves visualization and quantitation of macular neovascularization imaged by optical coherence tomography angiography.
    Zhang Q; Zhang A; Lee CS; Lee AY; Rezaei KA; Roisman L; Miller A; Zheng F; Gregori G; Durbin MK; An L; Stetson PF; Rosenfeld PJ; Wang RK
    Ophthalmol Retina; 2017; 1(2):124-136. PubMed ID: 28584883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration.
    Levine ES; Custo Greig E; Mendonça LSM; Gulati S; Despotovic IN; Alibhai AY; Moult E; Muakkassa N; Quaranta-El Maftouhi M; El Maftouhi A; Chakravarthy U; Fujimoto JG; Baumal CR; Witkin AJ; Duker JS; Hartnett ME; Waheed NK
    Int J Retina Vitreous; 2020; 6():39. PubMed ID: 32844038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal Imaging Features and Clinical Relevance of Subretinal Lipid Globules.
    Fernández-Avellaneda P; Freund KB; Wang RK; He Q; Zhang Q; Fragiotta S; Xu X; Ledesma-Gil G; Sugiura Y; Breazzano MP; Yannuzzi LA; Liakopoulos S; Sarraf D; Dolz-Marco R
    Am J Ophthalmol; 2021 Feb; 222():112-125. PubMed ID: 32918902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical coherence tomography angiography for the detection of macular neovascularization-comparison of en face versus cross-sectional view.
    Siggel R; Spital C; Lentzsch A; Liakopoulos S
    Eye (Lond); 2023 Feb; 37(2):256-262. PubMed ID: 34992250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.
    Yang J; Zhang Q; Motulsky EH; Thulliez M; Shi Y; Lyu C; de Sisternes L; Durbin MK; Feuer W; Wang RK; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2019 Dec; 208():1-11. PubMed ID: 31229464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BIOMARKERS OF NEOVASCULAR ACTIVITY IN AGE-RELATED MACULAR DEGENERATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Al-Sheikh M; Iafe NA; Phasukkijwatana N; Sadda SR; Sarraf D
    Retina; 2018 Feb; 38(2):220-230. PubMed ID: 28582276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of macular neovascularization in central serous chorioretinopathy using swept-source OCT angiography.
    Staropoli PC; Iyer P; Gregori G; Rosenfeld PJ; Flynn HW
    Am J Ophthalmol Case Rep; 2023 Jun; 30():101843. PubMed ID: 37092114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exudative non-neovascular age-related macular degeneration.
    Bacci T; Essilfie JO; Leong BCS; Freund KB
    Graefes Arch Clin Exp Ophthalmol; 2021 May; 259(5):1123-1134. PubMed ID: 33242167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment-naïve quiescent macular neovascularization secondary to AMD: The 2019 Young Investigator Lecture of Macula Society.
    Querques G; Sacconi R; Capuano V; Carnevali A; Colantuono D; Battista M; Borrelli E; Miere A; Parravano M; Costanzo E; Querques L; Souied EH; Bandello F
    Eur J Ophthalmol; 2021 Nov; 31(6):3164-3176. PubMed ID: 33445977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular Analysis of Type 1, 2, and 3 Macular Neovascularization in Age-Related Macular Degeneration Using Swept-Source Optical Coherence Tomography Angiography Shows New Insights into Differences of Pathologic Vasculature and May Lead to a More Personalized Understanding.
    Faatz H; Rothaus K; Ziegler M; Book M; Heimes-Bussmann B; Pauleikhoff D; Lommatzsch A
    Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical Coherence Tomography Angiography for Detecting Nonexudative Macular Neovascularization in Age-Related Macular Degeneration.
    Greenberg JR; Kim BY; Brady CJ; Millay RH; Raut R
    J Vitreoretin Dis; 2023; 7(1):16-19. PubMed ID: 37008398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY PARAMETER VARIATIONS AFTER TREATMENT OF MACULAR NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Arrigo A; Aragona E; Bordato A; Amato A; Borghesan F; Bandello F; Parodi MB
    Retina; 2021 Jul; 41(7):1463-1469. PubMed ID: 33315820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.